Literature DB >> 9020849

Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation.

L Mangiarini1, K Sathasivam, A Mahal, R Mott, M Seller, G P Bates.   

Abstract

Six inherited neurodegenerative diseases are caused by a CAG/polyglutamine expansion, including spinal and bulbar muscular atrophy (SBMA), Huntington's disease (HD), spinocerebellar ataxia type 1 (SCA1), dentatorubral pallidoluysian atrophy (DRPLA) Machado-Joseph disease (MJD or SCA3) and SCA2. Normal and expanded HD allele sizes of 6-39 and 35-121 repeats have been reported, and the allele distributions for the other diseases are comparable. Intergenerational instability has been described in all cases, and repeats tend to be more unstable on paternal transmission. This may present as larger increases on paternal inheritance as in HD, or as a tendency to increase on male and decrease on female transmission as in SCA1 (ref. 15). Somatic repeat instability is also apparent and appears most pronounced in the CNS. The major exception is the cerebellum, which in HD, DRPLA, SCA1 and MJD has a smaller repeat relative to the other brain regions tested. Of non-CNS tissues, instability was observed in blood, liver, kidney and colon. A mouse model of CAG repeat instability would be helpful in unravelling its molecular basis although an absence of CAG repeat instability in transgenic mice has so far been reported. These studies include (CAG) in the androgen receptor cDNA, (CAG) in the HD cDNA, (CAG) in the SCA1 cDNA, (CAG) in the SCA3 cDNA and as an isolated (CAG) tract.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020849     DOI: 10.1038/ng0297-197

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  102 in total

1.  FMR1 CGG-repeat instability in single sperm and lymphocytes of fragile-X premutation males.

Authors:  S L Nolin; G E Houck; A D Gargano; H Blumstein; C S Dobkin; W T Brown
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

Review 2.  Transgenic models of Huntington's disease.

Authors:  K Sathasivam; C Hobbs; L Mangiarini; A Mahal; M Turmaine; P Doherty; S W Davies; G P Bates
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

3.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

Authors:  J S Steffan; A Kazantsev; O Spasic-Boskovic; M Greenwald; Y Z Zhu; H Gohler; E E Wanker; G P Bates; D E Housman; L M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.

Authors:  Damian M Cummings; Yasaman Alaghband; Miriam A Hickey; Prasad R Joshi; S Candice Hong; Chunni Zhu; Timothy K Ando; Véronique M André; Carlos Cepeda; Joseph B Watson; Michael S Levine
Journal:  J Neurophysiol       Date:  2011-11-09       Impact factor: 2.714

5.  Chemically induced increases and decreases in the rate of expansion of a CAG*CTG triplet repeat.

Authors:  Mário Gomes-Pereira; Darren G Monckton
Journal:  Nucleic Acids Res       Date:  2004-05-20       Impact factor: 16.971

Review 6.  DNA secondary structure: a common and causative factor for expansion in human disease.

Authors:  C T McMurray
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  New insights into repeat instability: role of RNA•DNA hybrids.

Authors:  Elizabeth I McIvor; Urszula Polak; Marek Napierala
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

8.  Early Detection of Apathetic Phenotypes in Huntington's Disease Knock-in Mice Using Open Source Tools.

Authors:  Shawn Minnig; Robert M Bragg; Hardeep S Tiwana; Wes T Solem; William S Hovander; Eva-Mari S Vik; Madeline Hamilton; Samuel R W Legg; Dominic D Shuttleworth; Sydney R Coffey; Jeffrey P Cantle; Jeffrey B Carroll
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

9.  Chemotherapeutic deletion of CTG repeats in lymphoblast cells from DM1 patients.

Authors:  Vera I Hashem; Malgorzata J Pytlos; Elzbieta A Klysik; Kuniko Tsuji; Mehrdad Khajavi; Merhdad Khajav; Tetsuo Ashizawa; Richard R Sinden
Journal:  Nucleic Acids Res       Date:  2004-12-01       Impact factor: 16.971

10.  Counting CAG repeats in the Huntington's disease gene by restriction endonuclease EcoP15I cleavage.

Authors:  Elisabeth Möncke-Buchner; Stefanie Reich; Merlind Mücke; Monika Reuter; Walter Messer; Erich E Wanker; Detlev H Krüger
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.